EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers

Junaid Arshad, Amith Rao, Matthew L Repp, Rohit Rao, Clinton Wu iD, Juanita L Merchant iD

International Journal of Molecular Sciences · 04.03.2024 · 25 (5) · 2985

DOI: 10.3390/ijms25052985 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.03.2024. Verfasst von Junaid Arshad und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona Cancer Center, GI Medical Oncology, Tucson, AZ 85724, USA. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal cancers represent one of the more challenging cancers to treat. Current strategies to cure and control gastrointestinal (GI) cancers like surgery, radiation, chemotherapy, and immunotherapy have met with limited success, and research has turned towards further characterizing the tumor microenvironment to develop novel therapeutics. Myeloid-derived suppressor cells (MDSCs) have emerged as crucial drivers of pathogenesis and progression within the tumor microenvironment in GI malignancies. Many MDSCs clinical targets have been defined in preclinical models, that potentially play an integral role in blocking recruitment and expansion, promoting MDSC differentiation into mature myeloid cells, depleting existing MDSCs, altering MDSC metabolic pathways, and directly inhibiting MDSC function. This review article analyzes the role of MDSCs in GI cancers as viable therapeutic targets for gastrointestinal malignancies and reviews the existing clinical trial landscape of recently completed and ongoing clinical studies testing novel therapeutics in GI cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid-Derived Suppressor CellsGastrointestinal NeoplasmsHumansMyeloid CellsImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

CCR5CXCR2IDO-1MDSCPDEgastrointestinal cancertumor microenvironment

Autor:innen und Institutionen

  • University of Arizona Cancer Center, GI Medical Oncology, Tucson, AZ 85724, USA.
  • Banner University Medical Center-University of Arizona, Tucson, AZ 85719, USA.
  • College of Medicine, University of Arizona, Tucson, AZ 85719, USA.
  • University Hospitals Cleveland Medical Center, Case Western Reserve School of Medicine, Cleveland, OH 44106, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, USA.

ORCID-Profile: Clinton Wu, Juanita L Merchant

Förderung

  • NCI NIH HHS
  • NIH

Zitieren

APA

Arshad, J., Rao, A., Repp, M. L., Rao, R., Wu, C., & Merchant, J. L. (2024). Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences, 25(5), 2985. https://doi.org/10.3390/ijms25052985

Vancouver

Arshad J, Rao A, Repp ML, Rao R, Wu C, Merchant JL. Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences. 2024;25(5):2985. doi:10.3390/ijms25052985

BibTeX
@article{Arshad2024,
  author = {Arshad, Junaid and Rao, Amith and Repp, Matthew L and Rao, Rohit and Wu, Clinton and Merchant, Juanita L},
  title = {Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2985},
  doi = {10.3390/ijms25052985}
}
Kostenlos starten →